Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Sabra reports earnings after market close, meaning Day 0 reflects anticipatory trading before results are released, while Day +1 captures the market's first full reaction to the actual numbers.

Historical price behavior shows moderate volatility around earnings, with an average absolute Day 0 move of 1.36% and Day +1 move of 1.92%. The most significant reaction occurred following the November 2025 report, when shares declined 3.92% on Day +1 despite a modest 1.22% Day 0 gain. More recently, the August 2026 report triggered a 2.65% Day 0 decline followed by a muted 0.24% Day +1 recovery.

The data reveals asymmetric risk, with Day +1 ranges averaging 4.83%—more than double the Day 0 range of 2.32%. This suggests the market's initial reaction often proves incomplete, with substantial follow-through occurring in the session after results are digested. The February 2026 report exemplifies this pattern: a 3.32% Day 0 gain was followed by minimal Day +1 movement, while November 2025 saw a small Day 0 gain reverse sharply the next day. Investors should anticipate potential swings of 4-5% in the session following the earnings call.

Part 2.2: Options Market Expected Move

The options market is pricing an expected move of 4.95% (±$0.98) through the November 20 expiration, which is significantly higher than the average historical Day 0 move of 1.36% but roughly in line with the average Day +1 move of 1.92%. The implied move also aligns closely with the average Day +1 range of 4.83%, suggesting options traders are anticipating volatility consistent with recent post-earnings patterns.

Part 3: What Analysts Are Saying

Analysts maintain a cautiously optimistic stance on Sabra heading into earnings. The consensus rating stands at 3.71 (between Hold and Buy), with 6 Strong Buy ratings, 0 Moderate Buys, 11 Holds, and no Sell ratings among 17 analysts covering the stock. This distribution reflects a divided Street: roughly one-third see compelling value, while the majority prefer a wait-and-see approach.

The average price target of $22.36 implies 13.3% upside from the current price of $19.74, with estimates ranging from a low of $19.00 to a high of $25.00. The wide target range—spanning more than 30%—underscores differing views on Sabra's valuation and growth trajectory. Bulls point to the company's improving operational execution and attractive yield, while more cautious analysts cite sector headwinds and valuation concerns.

Sentiment has remained unchanged over the past month, with the rating distribution and average recommendation holding steady at 3.71. This stability suggests analysts are awaiting the Q3 results and management commentary before adjusting their views. The lack of recent upgrades or downgrades indicates the Street is positioned neutrally, with the upcoming earnings report likely to serve as a catalyst for renewed rating activity. Prior estimate revisions show the Q3 consensus ticking up from $0.38 to $0.39, reflecting modest optimism about the quarter's performance.

Part 4: Technical Picture

Sabra enters earnings with deteriorating technical momentum despite recent price stability. The Barchart Technical Opinion currently shows a 72% Sell signal, unchanged from last week but representing a sharp deterioration from the 16% Sell signal registered a month ago. This shift reflects growing bearish pressure as the stock has struggled to break above key resistance levels.

Timeframe Analysis:

• Short-term (50% Sell): Moderate sell signal indicates near-term momentum has turned negative, though not at extreme levels
• Medium-term (100% Sell): Strong sell signal across all intermediate timeframe indicators suggests consolidation or downtrend in the 20-50 day window
• Long-term (50% Sell): Moderate sell signal reflects weakness in the longer-term trend, though less pronounced than medium-term readings

Soft Weakening trend characteristics suggest the stock is experiencing gradual deterioration rather than sharp breakdown, with momentum indicators pointing lower but not yet oversold.

The stock is currently trading at $19.74, positioned above its 5-day ($19.53), 10-day ($19.42), and 20-day ($19.26) moving averages, indicating short-term relative strength. However, the price remains below its 50-day ($19.87), 100-day ($20.00), and 200-day ($19.97) moving averages, confirming the medium-term weakness flagged by technical indicators.

The technical setup presents a mixed picture heading into earnings. While the stock has maintained support above its short-term moving averages and trades near $19.74, the failure to reclaim the $20.00 level (100-day MA) and deteriorating momentum indicators suggest limited upside cushion. The 50-day moving average at $19.87 represents immediate resistance, while the 20-day average at $19.26 provides nearby support. With the Barchart Opinion showing broad-based sell signals and the stock trading below all major long-term averages, the technical backdrop is cautionary rather than supportive. A strong earnings beat and positive guidance would be needed to reverse the weakening momentum and trigger a breakout above the $20.00 resistance zone.